Tryptophan degradation in multiple trauma patients: Survivors compared with non-survivors

Clinical Science

Volumn 116, Issue 7, 2009, Pages 593-598

  Ploder, Martin ^a   Spittler, Andreas ^a   Schroecksnadel, Katharina ^b   Neurauter, Gabriele ^b   Pelinka, Linda E ^c   Roth, Erich ^a   Fuchs, Dietmar ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c FEDERAL RESEARCH AND TRAINING CENTRE FOR FORESTS   (Austria)

Author keywords

Indoleamine 2,3 dioxygenase (IDO); Kynurenine; Survival; Trauma; Tryptophan

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; TRYPTOPHAN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEATH; ENZYME ACTIVATION; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MALE; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; SURVIVOR; AGED; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; BIOLOGICAL MARKERS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; MALE; MIDDLE AGED; MULTIPLE TRAUMA; PROGNOSIS; TRYPTOPHAN; YOUNG ADULT;

EID: 65549101176     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080319     Document Type: Article

References (28)

1. Zedler, S. and Faist, E. (2006) The impact of endogenous triggers on trauma-associated inflammation. Curr. Opin. Crit. Care 12, 595-601
2. Taylor, M. W. and Feng, G. S. (1991) Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5, 2516-2522
3. Brown, R. R., Ozaki, Y., Datta, S. P., Borden, E. C., Sondel, P. M. and Malone, D. G. (1991) Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv. Exp. Med. Biol. 294, 425-435
4. Pfefferkorn, E. R. (1984) Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U.S.A. 81, 908-912
5. Carlin, J. M., Ozaki, Y., Byrne, G. I., Brown, R. R. and Borden, E. C. (1989) Interferons and indoleamine 2.3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 45, 535-541
6. Mellor, A. L. and Munn, D. H. (1999) Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today 20, 469-473
7. Pellegrin, K., Neurauter, G., Wirleitner, B., Fleming, A. W., Peterson, V. M. and Fuchs, D. (2005) Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. Shock 23, 209-215
8. Weiss, G., Murr, C., Zoller, H., Haun, M., Widner, B., Ludescher, C. and Fuchs, D. (1999) Modulation of neopterin formation and tryptophan degradation by Th1-and Th2-derived cytokines in human monocytic cells. Clin. Exp. Immunol. 116, 435-440
9. Wirleitner, B., Reider, D., Ebner, S., Böck, G., Widner, B., Jaeger, M., Schennach, H., Romani, N. and Fuchs, D. (2002) Monocyte-derived dendritic cells release neopterin. J. Leukocyte Biol. 72, 1148-1153
10. Fuchs, D., Moeller, A. A., Reibnegger, G., Werner, E. R., Werner-Felmayer, G., Dierich, M. P. and Wachter, H. (1991) Increased endogenous interferon-γ and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol. Lett. 28, 207-211
11. Wirleitner, B., Neurauter, G., Schröcksnadel, K., Frick, B. and Fuchs, D. (2003) Interferon-γ-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 10, 1581-1591
12. Pertovaara, M., Raitala, A., Juonala, M., Lehtimäki, T., Huhtala, H., Oja, S. S., Jokinen, E., Viikari, J. S., Raitakari, O. T. and Hurme, M. (2007) Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin. Exp. Immunol. 148, 106-111
13. Pertovaara, M., Raitala, A., Uusitalo, H., Pukander, J., Helin, H., Oja, S. S. and Hurme, M. (2005) Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjoegren's syndrome. Clin. Exp. Immunol. 142, 155-161
14. Strohmaier, W., Redl, H., Schlag, G. and Inthorn, D. (1987) D-Erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit. Care Med. 15, 757-760
15. Hensler, T., Sauerland, S., Lefering, R., Nagelschmidt, M., Bouillon, B., Andermahr, J. and Neugebauer, E. A. (2003) The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 20, 420-426
16. Widner, B., Werner, E. R., Schennach, H., Wachter, H. and Fuchs, D. (1997) Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43, 2424-2426
17. Laich, A., Neurauter, G., Widner, B. and Fuchs, D. (2002) More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin. Chem. 48, 579-581
18. Murr, C., Widner, B., Wirleitner, B. and Fuchs, D. (2002) Neopterin as a marker for immune system activation. Curr. Drug Metab. 3, 175-187
19. Wood, K. J. and Sawitzki, B. (2006) Interferon γ: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27, 183-187
20. Schroecksnadel, K. and Fuchs, D. (2006) Interferon-γ for counteracting T-cell activation. Trends Immunol. 27, 398
21. Giusti, R. M., Maloney, E. M., Hanchard, B., Morgan, O. S. C., Steinberg, S. M., Wachter, H., Williams, E., Cranston, B., Fuchs, D. and Manns, A. (1996) Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic pararesis and adult T-cell leukemia/ lymphoma. Cancer Epidemiol. Biomarkers Prevent. 5, 699-709
22. Brandacher, G., Perathoner, A., Ladurner, R., Schneeberger, S., Obrist, P., Winkler, C., Werner, E. R., Werner-Felmayer, G., Weiss, H. G., Goebel, G. et al. (2006) Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin. Cancer Res. 12, 1144-1151
23. Weinlich, G., Murr, C., Richardsen, L., Winkler, C. and Fuchs, D. (2007) Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. Dermatology 214, 8-14
24. Boasso, A. and Shearer, G. M. (2007) How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr. Drug Metab. 8, 217-223
25. Schroecksnadel, K., Zangerle, R., Bellmann-Weiler, R., Garimorth, K., Weiss, G. and Fuchs, D. (2007) Indoleamine-2,3-dioxygenase and other interferon-γ-mediated pathways in patients with human immunodeficiency virus infection. Curr. Drug Metab. 8, 225-236
26. Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H. and Opelz, G. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447-457
27. Widner, B., Laich, A., Sperner-Unterweger, B., Ledochowski, M. and Fuchs, D. (2002) Neopterin production tryptophan degradation and mental depression: what is the link? Brain Behav. Immun. 16, 590-595
28. Myint, A. M., Kim, Y. K., Verkerk, R., Scharpe, S., Steinbusch, H. and Leonard, B. (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J. Affect. Disord. 98, 143-151